Parkinson's disease, toxic exposure, and basal ganglia: A proton magnetic resonance spectroscopy study

被引：0
|
作者：
Rango, M
Righini, A
Farabola, M
Bettinelli, A
Scarlato, G
机构：
来源：
NEUROLOGY | 2000年 / 54卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：A445 / A445
页数：1
相关论文
共 50 条
  • [21] Parkinson's disease, exposure to toxic substances and basal nuclei
    Rango, M
    Farabola, M
    Canesi, M
    Castelli, A
    Righini, A
    Scarlato, G
    Antonini, A
    Egidi, M
    Pezzoli, G
    RIVISTA DI NEURORADIOLOGIA, 2001, 14 : 47 - 48
  • [22] Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders
    Federico, F
    Simone, IL
    Lucivero, V
    Iliceto, G
    DeMari, M
    Giannini, P
    Mezzapesa, DM
    Tarantino, A
    Lamberti, P
    MOVEMENT DISORDERS, 1997, 12 (06) : 903 - 909
  • [23] Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy
    Federico, F
    Simone, IL
    Lucivero, V
    DeMari, M
    Giannini, P
    Iliceto, G
    Mezzapesa, DM
    Lamberti, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (03): : 239 - 242
  • [24] Proton magnetic resonance spectroscopy in Parkinson's disease and parkinsonism plus syndromes
    Litvinenko, I. V.
    Pozdnyakov, A. V.
    Odinak, M. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 246 - 246
  • [25] PROTON MAGNETIC RESONANCE SPECTROSCOPY CHANGES IN PARKINSON'S DISEASE WITH AND WITHOUT PSYCHOSIS
    Rodriguez-Violante, Mayela
    Cervantes-Arriaga, Amin
    Gonzalez-Latapi, Paulina
    Leon-Ortiz, Pablo
    de la Fuente-Sandoval, Camilo
    Corona, Teresa
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2015, 67 (04): : 227 - 234
  • [26] Magnetic resonance spectroscopy in Parkinson's disease
    Khomenko, Y. G.
    Miliukhina, I., V
    Gracheva, E., V
    Kataeva, G., V
    Bogdan, A. A.
    Gromova, E. A.
    Susin, D. S.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 150 - 160
  • [27] Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study
    Renshaw, PF
    Lafer, B
    Babb, SM
    Fava, M
    Stoll, AL
    Christensen, JD
    Moore, CM
    YurgelunTodd, DA
    Bonello, CM
    Pillay, SS
    Rothschild, AJ
    Nierenberg, AA
    Rosenbaum, JF
    Bruce, BM
    BIOLOGICAL PSYCHIATRY, 1997, 41 (08) : 837 - 843
  • [28] Proton and phosphorus magnetic resonance spectroscopy in Parkinson's disease: A systematic review.
    Bis, S.
    Nirenberg, M. J.
    Shungu, D. C.
    Henchcliffe, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S52 - S52
  • [29] A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease
    Firbank, MJ
    Harrison, RM
    O'Brien, JT
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (02) : 64 - 76
  • [30] Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease
    Zhou, Bing
    Yuan, Fangzhen
    He, Zhong
    Tan, Changlian
    BRAIN IMAGING AND BEHAVIOR, 2014, 8 (01) : 97 - 101
12345